Indolizino[3,2-c]quinoline derivatives, pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition for treatment of cystic fibrosis containing the same as active ingredient
申请人:INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
公开号:US09296751B1
公开(公告)日:2016-03-29
Provided are an indolizino[3,2-c]quinoline derivative, pharmaceutically acceptable salt thereof, and a method for preparing the same. The indolizino[3,2-c]quinoline derivative, pharmaceutically acceptable salt thereof may function as an agonist of cystic fibrosis conductance transmembrane regulator, and thus may be useful for an agent for preventing or treating diseases caused by degradation of activity of cystic fibrosis conductance transmembrane regulator and for a pharmaceutical composition for stimulating proliferation of stem cells.
提供了一种吲哚并[3,2-c]喹啉衍生物,其药用盐,以及制备该衍生物的方法。该吲哚并[3,2-c]喹啉衍生物和其药用盐可以作为囊性纤维化传导跨膜调节蛋白的激动剂,因此可用作预防或治疗由于囊性纤维化传导跨膜调节蛋白活性降解而引起的疾病的药剂,以及用于刺激干细胞增殖的药物组合物。